Position history for Skandinaviska Enskilda Banken AB (publ)'s holdings in VERTEX PHARMACEUTICALS INC
Skandinaviska Enskilda Banken AB (publ) holds 46,000 shares of VRTX (VERTEX PHARMACEUTICALS INC), worth $20.5M as of 2026-Q1. The position was decreased (-73.6% shares). VRTX represents 0.5% of Skandinaviska Enskilda Banken AB (publ)'s portfolio.
Current Value
$20.5M
Current Shares
46,000
Total Value Change
-$82M
Total Shares Change
-172,833
Other major holders of VRTX: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Decreased |
| 46,000 |
-73.6% |
| $20.5M |
| 0.5% |
| $474.27 |
0 |
| 2025-Q4 | Increased | 174,466 | +13.1% | $79.1M | 0.3% | $453.74 | 40 |
| 2025-Q3 | Decreased | 154,248 | -12.7% | $60.4M | 0.2% | $395.31 | 0 |
| 2025-Q2 | Decreased | 176,604 | -5.3% | $78.6M | 0.3% | $441.30 | 0 |
| 2025-Q1 | Increased | 186,471 | +9.0% | $90.4M | 0.4% | $492.69 | 39 |
| 2024-Q4 | Decreased | 171,034 | -7.7% | $68.3M | 0.3% | $399.35 | 0 |
| 2024-Q3 | Decreased | 185,285 | -15.3% | $86.2M | 0.4% | $462.88 | 0 |
| 2024-Q2 | Decreased | 218,833 | -17.4% | $102.5M | 0.5% | $468.72 | 0 |